The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nausea And Vomiting Treatment Market Research Report 2025

Global Nausea And Vomiting Treatment Market Research Report 2025

Publishing Date : Apr, 2025

License Type :
 

Report Code : 1705438

No of Pages : 84

Ask Your Query
Synopsis
The global market for Nausea And Vomiting Treatment was valued at US$ 5887 million in the year 2024 and is projected to reach a revised size of US$ 9093 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
This report aims to provide a comprehensive presentation of the global market for Nausea And Vomiting Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nausea And Vomiting Treatment.
The Nausea And Vomiting Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nausea And Vomiting Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nausea And Vomiting Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Pharmanovia
Mylan
Duchesnay
GSK
Segment by Type
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others
Segment by Application
CINV
PONV
Motion Sickness
Pregnancy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nausea And Vomiting Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Serotonin Receptor Antagonist
1.2.3 Neurokinin NK1 Receptor Antagonist
1.2.4 Others
1.3 Market by Application
1.3.1 Global Nausea And Vomiting Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 CINV
1.3.3 PONV
1.3.4 Motion Sickness
1.3.5 Pregnancy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nausea And Vomiting Treatment Market Perspective (2020-2031)
2.2 Global Nausea And Vomiting Treatment Growth Trends by Region
2.2.1 Global Nausea And Vomiting Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nausea And Vomiting Treatment Historic Market Size by Region (2020-2025)
2.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Region (2026-2031)
2.3 Nausea And Vomiting Treatment Market Dynamics
2.3.1 Nausea And Vomiting Treatment Industry Trends
2.3.2 Nausea And Vomiting Treatment Market Drivers
2.3.3 Nausea And Vomiting Treatment Market Challenges
2.3.4 Nausea And Vomiting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nausea And Vomiting Treatment Players by Revenue
3.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2020-2025)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nausea And Vomiting Treatment Revenue
3.4 Global Nausea And Vomiting Treatment Market Concentration Ratio
3.4.1 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nausea And Vomiting Treatment Revenue in 2024
3.5 Global Key Players of Nausea And Vomiting Treatment Head office and Area Served
3.6 Global Key Players of Nausea And Vomiting Treatment, Product and Application
3.7 Global Key Players of Nausea And Vomiting Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nausea And Vomiting Treatment Breakdown Data by Type
4.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2020-2025)
4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2026-2031)
5 Nausea And Vomiting Treatment Breakdown Data by Application
5.1 Global Nausea And Vomiting Treatment Historic Market Size by Application (2020-2025)
5.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nausea And Vomiting Treatment Market Size (2020-2031)
6.2 North America Nausea And Vomiting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nausea And Vomiting Treatment Market Size by Country (2020-2025)
6.4 North America Nausea And Vomiting Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nausea And Vomiting Treatment Market Size (2020-2031)
7.2 Europe Nausea And Vomiting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nausea And Vomiting Treatment Market Size by Country (2020-2025)
7.4 Europe Nausea And Vomiting Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nausea And Vomiting Treatment Market Size (2020-2031)
8.2 Asia-Pacific Nausea And Vomiting Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nausea And Vomiting Treatment Market Size (2020-2031)
9.2 Latin America Nausea And Vomiting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nausea And Vomiting Treatment Market Size by Country (2020-2025)
9.4 Latin America Nausea And Vomiting Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nausea And Vomiting Treatment Market Size (2020-2031)
10.2 Middle East & Africa Nausea And Vomiting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Details
11.1.2 Merck & Co. Inc. Business Overview
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction
11.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.1.5 Merck & Co. Inc. Recent Development
11.2 Helsinn Group
11.2.1 Helsinn Group Company Details
11.2.2 Helsinn Group Business Overview
11.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction
11.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.2.5 Helsinn Group Recent Development
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Details
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Details
11.4.2 Kyowa Kirin Business Overview
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction
11.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.4.5 Kyowa Kirin Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Nausea And Vomiting Treatment Introduction
11.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Details
11.6.2 Qilu Pharma Business Overview
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction
11.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.6.5 Qilu Pharma Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Details
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.8 Taiji group
11.8.1 Taiji group Company Details
11.8.2 Taiji group Business Overview
11.8.3 Taiji group Nausea And Vomiting Treatment Introduction
11.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.8.5 Taiji group Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Nausea And Vomiting Treatment Introduction
11.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Details
11.10.2 Heron Therapeutics Business Overview
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction
11.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.10.5 Heron Therapeutics Recent Development
11.11 Pharmanovia
11.11.1 Pharmanovia Company Details
11.11.2 Pharmanovia Business Overview
11.11.3 Pharmanovia Nausea And Vomiting Treatment Introduction
11.11.4 Pharmanovia Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.11.5 Pharmanovia Recent Development
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Nausea And Vomiting Treatment Introduction
11.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.12.5 Mylan Recent Development
11.13 Duchesnay
11.13.1 Duchesnay Company Details
11.13.2 Duchesnay Business Overview
11.13.3 Duchesnay Nausea And Vomiting Treatment Introduction
11.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.13.5 Duchesnay Recent Development
11.14 GSK
11.14.1 GSK Company Details
11.14.2 GSK Business Overview
11.14.3 GSK Nausea And Vomiting Treatment Introduction
11.14.4 GSK Revenue in Nausea And Vomiting Treatment Business (2020-2025)
11.14.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Nausea And Vomiting Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Serotonin Receptor Antagonist
Table 3. Key Players of Neurokinin NK1 Receptor Antagonist
Table 4. Key Players of Others
Table 5. Global Nausea And Vomiting Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Nausea And Vomiting Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nausea And Vomiting Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Nausea And Vomiting Treatment Market Share by Region (2020-2025)
Table 9. Global Nausea And Vomiting Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Nausea And Vomiting Treatment Market Share by Region (2026-2031)
Table 11. Nausea And Vomiting Treatment Market Trends
Table 12. Nausea And Vomiting Treatment Market Drivers
Table 13. Nausea And Vomiting Treatment Market Challenges
Table 14. Nausea And Vomiting Treatment Market Restraints
Table 15. Global Nausea And Vomiting Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Nausea And Vomiting Treatment Market Share by Players (2020-2025)
Table 17. Global Top Nausea And Vomiting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2024)
Table 18. Ranking of Global Top Nausea And Vomiting Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Nausea And Vomiting Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Nausea And Vomiting Treatment, Headquarters and Area Served
Table 21. Global Key Players of Nausea And Vomiting Treatment, Product and Application
Table 22. Global Key Players of Nausea And Vomiting Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nausea And Vomiting Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Nausea And Vomiting Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Nausea And Vomiting Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Nausea And Vomiting Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Nausea And Vomiting Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Nausea And Vomiting Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Nausea And Vomiting Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Nausea And Vomiting Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Nausea And Vomiting Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Merck & Co. Inc. Company Details
Table 48. Merck & Co. Inc. Business Overview
Table 49. Merck & Co. Inc. Nausea And Vomiting Treatment Product
Table 50. Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 51. Merck & Co. Inc. Recent Development
Table 52. Helsinn Group Company Details
Table 53. Helsinn Group Business Overview
Table 54. Helsinn Group Nausea And Vomiting Treatment Product
Table 55. Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 56. Helsinn Group Recent Development
Table 57. Unimed Pharmaceuticals (AbbVie Inc.) Company Details
Table 58. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
Table 59. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product
Table 60. Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 61. Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
Table 62. Kyowa Kirin Company Details
Table 63. Kyowa Kirin Business Overview
Table 64. Kyowa Kirin Nausea And Vomiting Treatment Product
Table 65. Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 66. Kyowa Kirin Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Nausea And Vomiting Treatment Product
Table 70. Sanofi Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Qilu Pharma Company Details
Table 73. Qilu Pharma Business Overview
Table 74. Qilu Pharma Nausea And Vomiting Treatment Product
Table 75. Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 76. Qilu Pharma Recent Development
Table 77. Teva Pharmaceutical Industries Ltd. Company Details
Table 78. Teva Pharmaceutical Industries Ltd. Business Overview
Table 79. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product
Table 80. Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 81. Teva Pharmaceutical Industries Ltd. Recent Development
Table 82. Taiji group Company Details
Table 83. Taiji group Business Overview
Table 84. Taiji group Nausea And Vomiting Treatment Product
Table 85. Taiji group Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 86. Taiji group Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Nausea And Vomiting Treatment Product
Table 90. Novartis Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Heron Therapeutics Company Details
Table 93. Heron Therapeutics Business Overview
Table 94. Heron Therapeutics Nausea And Vomiting Treatment Product
Table 95. Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 96. Heron Therapeutics Recent Development
Table 97. Pharmanovia Company Details
Table 98. Pharmanovia Business Overview
Table 99. Pharmanovia Nausea And Vomiting Treatment Product
Table 100. Pharmanovia Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 101. Pharmanovia Recent Development
Table 102. Mylan Company Details
Table 103. Mylan Business Overview
Table 104. Mylan Nausea And Vomiting Treatment Product
Table 105. Mylan Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 106. Mylan Recent Development
Table 107. Duchesnay Company Details
Table 108. Duchesnay Business Overview
Table 109. Duchesnay Nausea And Vomiting Treatment Product
Table 110. Duchesnay Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 111. Duchesnay Recent Development
Table 112. GSK Company Details
Table 113. GSK Business Overview
Table 114. GSK Nausea And Vomiting Treatment Product
Table 115. GSK Revenue in Nausea And Vomiting Treatment Business (2020-2025) & (US$ Million)
Table 116. GSK Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report


List of Figures
Figure 1. Nausea And Vomiting Treatment Picture
Figure 2. Global Nausea And Vomiting Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nausea And Vomiting Treatment Market Share by Type: 2024 VS 2031
Figure 4. Serotonin Receptor Antagonist Features
Figure 5. Neurokinin NK1 Receptor Antagonist Features
Figure 6. Others Features
Figure 7. Global Nausea And Vomiting Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Nausea And Vomiting Treatment Market Share by Application: 2024 VS 2031
Figure 9. CINV Case Studies
Figure 10. PONV Case Studies
Figure 11. Motion Sickness Case Studies
Figure 12. Pregnancy Case Studies
Figure 13. Others Case Studies
Figure 14. Nausea And Vomiting Treatment Report Years Considered
Figure 15. Global Nausea And Vomiting Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nausea And Vomiting Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nausea And Vomiting Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Nausea And Vomiting Treatment Market Share by Players in 2024
Figure 19. Global Top Nausea And Vomiting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nausea And Vomiting Treatment Revenue in 2024
Figure 21. North America Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nausea And Vomiting Treatment Market Share by Country (2020-2031)
Figure 23. United States Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nausea And Vomiting Treatment Market Share by Country (2020-2031)
Figure 27. Germany Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nausea And Vomiting Treatment Market Share by Region (2020-2031)
Figure 35. China Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nausea And Vomiting Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nausea And Vomiting Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nausea And Vomiting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck & Co. Inc. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 51. Helsinn Group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 52. Unimed Pharmaceuticals (AbbVie Inc.) Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 53. Kyowa Kirin Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 54. Sanofi Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 55. Qilu Pharma Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 57. Taiji group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 59. Heron Therapeutics Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 60. Pharmanovia Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 61. Mylan Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 62. Duchesnay Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 63. GSK Revenue Growth Rate in Nausea And Vomiting Treatment Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock